Page 27 - Financial Review. Brendon Lau
Credit Suisse lists CPB as one of its top 5 small-cap buys as it is anticipating that the positive momentum will continue into 2011-12, given the strength in leading indicators such as the number of equity raisings in the resources sector to fund exploration and mine expansion and intense interest in gold.
Other factors boosting the stock include market share gains in the lab business, favourable trends that are likely to support demand for its environmental business over the med term and acquisitions, with management close to closing a small US takeover and pursuing deals in Europe ranging between 50-100m
Credit Suisse has a price target of $45.
Pep
:)
Add to My Watchlist
What is My Watchlist?